108 related articles for article (PubMed ID: 8272856)
1. The JANUS serum bank.
Jellum E; Andersen A; Lund-Larsen P; Theodorsen L; Orjasaeter H
Sci Total Environ; 1993 Nov; 139-140():527-35. PubMed ID: 8272856
[TBL] [Abstract][Full Text] [Related]
2. Experiences of the Janus Serum Bank in Norway.
Jellum E; Andersen A; Lund-Larsen P; Theodorsen L; Orjasaeter H
Environ Health Perspect; 1995 Apr; 103 Suppl 3(Suppl 3):85-8. PubMed ID: 7635118
[TBL] [Abstract][Full Text] [Related]
3. Cohort Profile Update: The Janus Serum Bank Cohort in Norway.
Hjerkind KV; Gislefoss RE; Tretli S; Nystad W; Bjørge T; Engeland A; Meyer HE; Holvik K; Ursin G; Langseth H
Int J Epidemiol; 2017 Aug; 46(4):1101-1102f. PubMed ID: 28087783
[No Abstract] [Full Text] [Related]
4. Serum thyroglobulin as a preclinical tumour marker in subgroups of thyroid cancer.
Thoresen SO; Myking O; Glattre E; Rootwelt K; Andersen A; Foss OP
Br J Cancer; 1988 Jan; 57(1):105-8. PubMed ID: 3348941
[TBL] [Abstract][Full Text] [Related]
5. Women who develop ovarian cancer show an increase in serum calcium and a decrease in serum albumin. A longitudinal study in the Janus Serum Bank Cohort.
Schwartz GG; Tretli S; Klug MG; Robsahm TE
Gynecol Oncol; 2020 Oct; 159(1):264-269. PubMed ID: 32723677
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of trace elements associated with antioxidant enzymes in blood of primary epithelial ovarian cancer patients.
Caglayan A; Katlan DC; Tuncer ZS; Yüce K
J Trace Elem Med Biol; 2019 Mar; 52():254-262. PubMed ID: 30732891
[TBL] [Abstract][Full Text] [Related]
7. Cohort Profile: The Janus Serum Bank Cohort in Norway.
Langseth H; Gislefoss RE; Martinsen JI; Dillner J; Ursin G
Int J Epidemiol; 2017 Apr; 46(2):403-404g. PubMed ID: 27063606
[No Abstract] [Full Text] [Related]
8. Prospective study of serum micronutrients and ovarian cancer.
Helzlsouer KJ; Alberg AJ; Norkus EP; Morris JS; Hoffman SC; Comstock GW
J Natl Cancer Inst; 1996 Jan; 88(1):32-7. PubMed ID: 8847723
[TBL] [Abstract][Full Text] [Related]
9. HE4 as an Early Detection Biomarker of Epithelial Ovarian Cancer: Investigations in Prediagnostic Specimens From the Janus Serumbank.
Gislefoss RE; Langseth H; Bolstad N; Nustad K; Mørkrid L
Int J Gynecol Cancer; 2015 Nov; 25(9):1608-15. PubMed ID: 26501436
[TBL] [Abstract][Full Text] [Related]
10. Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
Huang J; Mondul AM; Weinstein SJ; Koutros S; Derkach A; Karoly E; Sampson JN; Moore SC; Berndt SI; Albanes D
Br J Cancer; 2016 Oct; 115(9):1087-1095. PubMed ID: 27673363
[TBL] [Abstract][Full Text] [Related]
11. Elevated serum CA 125 levels prior to diagnosis of ovarian neoplasia: relevance for early detection of ovarian cancer.
Zurawski VR; Orjaseter H; Andersen A; Jellum E
Int J Cancer; 1988 Nov; 42(5):677-80. PubMed ID: 3182103
[TBL] [Abstract][Full Text] [Related]
12. Serum mucin antigens CASA and MSA in tumors of the breast, ovary, lung, pancreas, bladder, colon, and prostate. A blind trial with 420 patients.
Devine PL; McGuckin MA; Ramm LE; Ward BG; Pee D; Long S
Cancer; 1993 Sep; 72(6):2007-15. PubMed ID: 7689923
[TBL] [Abstract][Full Text] [Related]
13. Identification of candidate biomarkers using the Experion™ automated electrophoresis system in serum samples from ovarian cancer patients.
Kim JH; Kim YW; Kim IW; Park DC; Kim YW; Lee KH; Jang CK; Ahn WS
Int J Oncol; 2013 Apr; 42(4):1257-62. PubMed ID: 23443953
[TBL] [Abstract][Full Text] [Related]
14. Serum organochlorine levels and breast cancer: a nested case-control study of Norwegian women.
Ward EM; Schulte P; Grajewski B; Andersen A; Patterson DG; Turner W; Jellum E; Deddens JA; Friedland J; Roeleveld N; Waters M; Butler MA; DiPietro E; Needham LL
Cancer Epidemiol Biomarkers Prev; 2000 Dec; 9(12):1357-67. PubMed ID: 11142422
[TBL] [Abstract][Full Text] [Related]
15. Prediagnostic serum calcium and albumin and ovarian cancer: A nested case-control study in the Norwegian Janus Serum Bank Cohort.
Schwartz GG; Tretli S; Vos L; Robsahm TE
Cancer Epidemiol; 2017 Aug; 49():225-230. PubMed ID: 28732327
[TBL] [Abstract][Full Text] [Related]
16. CA125 and placental alkaline phosphatase as serum tumor markers in epithelial ovarian carcinoma.
Vergote IB; Abeler VM; Børmer OP; Stigbrand T; Tropé C; Nustad K
Tumour Biol; 1992; 13(3):168-74. PubMed ID: 1626181
[TBL] [Abstract][Full Text] [Related]
17. Predictive values of serum tumour markers tetranectin, OVX1, CASA and CA125 in patients with a pelvic mass.
Hogdall EV; Høgdall CK; Tingulstad S; Hagen B; Nustad K; Xu FJ; Bast RC; Jacobs IJ
Int J Cancer; 2000 Nov; 89(6):519-23. PubMed ID: 11102897
[TBL] [Abstract][Full Text] [Related]
18. Prediagnostic serum selenium in a case-control study of thyroid cancer.
Glattre E; Thomassen Y; Thoresen SO; Haldorsen T; Lund-Larsen PG; Theodorsen L; Aaseth J
Int J Epidemiol; 1989 Mar; 18(1):45-9. PubMed ID: 2722382
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis and follow-up of ovarian cancer by a combination assay of serum sialyl SSEA-1 antigen and CA125 levels].
Iwanari O; Miyako J; Date Y; Moriyama M; Yoshino N; Kijima S; Nakayama S; Ryuhkoh K; Moriyama M; Hata T
Nihon Gan Chiryo Gakkai Shi; 1989 Jun; 24(6):1256-60. PubMed ID: 2571650
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the novel serum markers B7-H4, Spondin 2, and DcR3 for diagnosis and early detection of ovarian cancer.
Simon I; Liu Y; Krall KL; Urban N; Wolfert RL; Kim NW; McIntosh MW
Gynecol Oncol; 2007 Jul; 106(1):112-8. PubMed ID: 17490732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
